Related Experiment Video

Updated: Jun 2, 2026

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Treatment of indeterminate cell histiocytosis with pravastatin

Molly V Burns, Ammar Ahmed, Gabriela Blanco Callahan

    Journal of the American Academy of Dermatology
    |April 19, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Assays for Validating Histone Acetyltransferase Inhibitors
    09:11

    Assays for Validating Histone Acetyltransferase Inhibitors

    Published on: August 6, 2020

    Related Experiment Videos

    Last Updated: Jun 2, 2026

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
    08:29

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

    Published on: October 2, 2014

    Assays for Validating Histone Acetyltransferase Inhibitors
    09:11

    Assays for Validating Histone Acetyltransferase Inhibitors

    Published on: August 6, 2020

    Related Concept Videos

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Coronary Artery Embolism From Atrial Flutter Presenting as Cardiac Arrest and ST-Elevation Myocardial Infarction: Diagnostic and Therapeutic Challenges.

    The American journal of case reports·2026

    The Thin Edge of the Wedge: Injectable Cosmetics in Dentistry.

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026

    Granulomatosis With Polyangiitis Presenting as Pulmonary Masses With Coexisting Infection: A Diagnostic Challenge Leading to Life-Threatening Pulmonary-Renal Syndrome.

    Cureus·2026

    Agreement Between HbA1C and Continuous Glucose Monitoring-Derived Glycemic Metrics in Adults With Cystic Fibrosis Related Diabetes.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026

    Ectopic Adrenocorticotropic Hormone Syndrome Secondary to Pulmonary Neuroendocrine Tumor: Medical Stabilization Enables Serial Imaging and Localization.

    AACE endocrinology and diabetes·2026

    31-Gene expression profiling for cutaneous melanoma: an expert consensus panel.

    Dermatology online journal·2026

    Pediatric Alopecia Areata and JAK Inhibitors: Bridging the Gap Between Evidence and Practice.

    Journal of the American Academy of Dermatology·2026

    Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.

    Journal of the American Academy of Dermatology·2026

    Comparison of Performance of Publicly Available Polygenic Risk Scores to Predict Clinically Actionable Coronary Artery Calcium Scores: The BioHEART-CT Cohort.

    European journal of preventive cardiology·2026

    Intracoronary Imaging-Guided Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Trials.

    Journal of the American College of Cardiology·2026

    Who can benefit from percutaneous left atrial appendage closure? Recent advances.

    Polish archives of internal medicine·2026

    Concomitant Left Ventricular and Popliteal Thrombectomy With Coronary Artery Bypass Grafting.

    Journal of investigative medicine high impact case reports·2026

    Longitudinal comparison of serum creatinine, estimated glomerular filtration rate, and blood urea nitrogen-to-creatinine ratio after initiation of palbociclib or abemaciclib: A single-center retrospective study.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    When the Clot Runs Deep: Tackling High Thrombus Burden in Primary Percutaneous Coronary Intervention.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us